Peanut Allergy Treatment Market
Peanut Allergy Treatment Market - Global Industry Assessment & Forecast
Segments Covered
- By Drug Class Antihistamines, Epinephrine, Immunotherapies, Other Drug Classes
- By Route of Administration Oral, Injectable, Other Routes of Administration
- By Distribution Channel Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 478.2 Million |
Revenue 2032: | USD 1278.3 Million |
Revenue CAGR (2024 - 2032): | 11.6% |
Fastest Growing Region (2024 - 2032) | Asia Pacific |
Largest Region (2023): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Peanut Allergy Treatment Market - Segment Analysis
- Overview
- Global Peanut Allergy Treatment Market, 2016 - 2028 (USD Million)
-
Global Peanut Allergy Treatment Market - by Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
-
Global Peanut Allergy Treatment Market - by Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
-
Global Peanut Allergy Treatment Market - by Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
-
Global Peanut Allergy Treatment Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Peanut Allergy Treatment Market - Segment Analysis
- Overview
- North America Peanut Allergy Treatment Market, 2016 - 2028 (USD Million)
-
North America Peanut Allergy Treatment Market, by Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
-
North America Peanut Allergy Treatment Market, by Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
-
North America Peanut Allergy Treatment Market, by Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
-
North America Peanut Allergy Treatment Market, by Country
- U.S.
- U.S. Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- U.S. Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- U.S. Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- U.S. Peanut Allergy Treatment Market, By Drug Class
- Canada
- Canada Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Canada Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Canada Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Canada Peanut Allergy Treatment Market, By Drug Class
- Mexico
- Mexico Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Mexico Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Mexico Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Mexico Peanut Allergy Treatment Market, By Drug Class
- U.S.
-
Europe Peanut Allergy Treatment Market - Segment Analysis
- Overview
- Europe Peanut Allergy Treatment Market, 2016 - 2028 (USD Million)
-
Europe Peanut Allergy Treatment Market, by Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
-
Europe Peanut Allergy Treatment Market, by Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
-
Europe Peanut Allergy Treatment Market, by Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
-
Europe Peanut Allergy Treatment Market, by Country
- Germany
- Germany Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Germany Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Germany Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Germany Peanut Allergy Treatment Market, By Drug Class
- UK
- UK Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- UK Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- UK Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- UK Market, By Drug Class
- France
- France Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- France Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- France Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- France Peanut Allergy Treatment Market, By Drug Class
- Spain
- Spain Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Spain Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Spain Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Spain Peanut Allergy Treatment Market, By Drug Class
- Italy
- Italy Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Italy Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Italy Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Italy Peanut Allergy Treatment Market, By Drug Class
- BENELUX
- BENELUX Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- BENELUX Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- BENELUX Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- BENELUX Peanut Allergy Treatment Market, By Drug Class
- Rest of Europe
- Rest Of Europe Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Rest Of Europe Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Rest Of Europe Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Rest Of Europe Peanut Allergy Treatment Market, By Drug Class
- Germany
-
Asia Pacific Peanut Allergy Treatment Market - Segment Analysis
- Overview
- Asia Pacific Peanut Allergy Treatment Market, 2016 - 2028 (USD Million)
-
Asia Pacific Peanut Allergy Treatment Market, by Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
-
Asia Pacific Peanut Allergy Treatment Market, by Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
-
Asia Pacific Peanut Allergy Treatment Market, by Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
-
Asia Pacific Peanut Allergy Treatment Market, by Country
- China
- China Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- China Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- China Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- China Peanut Allergy Treatment Market, By Drug Class
- Japan
- Japan Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Japan Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Japan Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Japan Peanut Allergy Treatment Market, By Drug Class
- India
- India Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- India Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- India Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- India Peanut Allergy Treatment Market, By Drug Class
- South Korea
- South Korea Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- South Korea Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- South Korea Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- South Korea Peanut Allergy Treatment Market, By Drug Class
- South East Asia
- South East Asia Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- South East Asia Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- South East Asia Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- South East Asia Peanut Allergy Treatment Market, By Drug Class
- Rest of Asia Pacific
- Rest of Asia Pacific Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Rest of Asia Pacific Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Rest of Asia Pacific Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Rest of Asia Pacific Peanut Allergy Treatment Market, By Drug Class
- China
-
Latin America Peanut Allergy Treatment Market - Segment Analysis
- Overview
- Latin America Peanut Allergy Treatment Market, 2016 - 2028 (USD Million)
-
Latin America Peanut Allergy Treatment Market, by Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
-
Latin America Peanut Allergy Treatment Market, by Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
-
Latin America Peanut Allergy Treatment Market, by Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
-
Latin America Peanut Allergy Treatment Market, by Country
- Brazil
- Brazil Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Brazil Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Brazil Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Brazil Peanut Allergy Treatment Market, By Drug Class
- Argentina
- Argentina Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Argentina Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Argentina Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Argentina Peanut Allergy Treatment Market, By Drug Class
- Rest of Latin America
- Rest of Latin America Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Rest of Latin America Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Rest of Latin America Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Rest of Latin America Peanut Allergy Treatment Market, By Drug Class
- Brazil
-
Middle East & Africa Peanut Allergy Treatment Market - Segment Analysis
- Overview
- Middle East & Africa Peanut Allergy Treatment Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Peanut Allergy Treatment Market, by Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
-
Middle East & Africa Peanut Allergy Treatment Market, by Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
-
Middle East & Africa Peanut Allergy Treatment Market, by Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
-
Middle East & Africa Peanut Allergy Treatment Market, by Country
- GCC Countries
- GCC Countries Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- GCC Countries Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- GCC Countries Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- GCC Countries Peanut Allergy Treatment Market, By Drug Class
- South Africa
- South Africa Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- South Africa Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- South Africa Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- South Africa Peanut Allergy Treatment Market, By Drug Class
- Rest of Middle East & Africa
- Rest of Middle East & Africa Peanut Allergy Treatment Market, By Drug Class
- By Antihistamines
- By Epinephrine
- By Immunotherapies
- By Other Drug Classes
- Rest of Middle East & Africa Peanut Allergy Treatment Market, By Route of Administration
- By Oral
- By Injectable
- By Other Routes of Administration
- Rest of Middle East & Africa Peanut Allergy Treatment Market, By Distribution Channel
- By Hospital Pharmacy
- By Retail Pharmacy
- By Other Distribution Channels
- Rest of Middle East & Africa Peanut Allergy Treatment Market, By Drug Class
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Alladapt Immunotherapeutics Inc. (U.S.)
- DBV Technologies (France)
- Aimmune Therapeutics Inc. (U.S.)
- Aravax Pty Ltd. (Australia)
- Sanofi (France)
- Vedanta Biosciences Inc. (U.S.)
- Regeneron Pharmaceuticals Inc. (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Prota Therapeutics (Australia)
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Peanut Allergy Treatment in terms of revenue?
-
The global Peanut Allergy Treatment valued at USD 478.2 Million in 2023 and is expected to reach USD 1278.3 Million in 2032 growing at a CAGR of 11.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Alladapt Immunotherapeutics Inc. (U.S.), DBV Technologies (France), Aimmune Therapeutics Inc. (U.S.), Aravax Pty Ltd. (Australia), Sanofi (France), Vedanta Biosciences Inc. (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Prota Therapeutics (Australia).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.6% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Peanut Allergy Treatment include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Peanut Allergy Treatment in 2023.